Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome

Oncogene

Volumn 23, Issue 35, 2004, Pages 5871-5879

  Foster, Christopher S ^a   Falconer, Alison ^b   Dodson, Andrew R ^a   Norman, Andrew R ^c   Dennis, Nening ^b   Fletcher, Anne ^b   Southgate, Christine ^b   Dowe, Anna ^c   Dearnaley, David ^c   Jhavar, Sameer ^b   Eeles, Rosalind ^b   Feber, Andrew ^b   Cooper, Colin S ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

E2F3 gene; EZH2 gene; Prostate cancer

Indexed keywords

TRANSCRIPTION FACTOR E2F3; E2F3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CELL NUCLEUS; CONTROLLED STUDY; DNA MICROARRAY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; CHEMISTRY; GENE AMPLIFICATION; GENETICS; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; E2F3 TRANSCRIPTION FACTOR; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 4043119132     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207800     Document Type: Article

References (36)

1. Bostwick DG and Foster CS. (1999). Semin. Urol. Oncol., 17, 222-272.
2. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E and Helin K. (2003). EMBO J., 22, 5323-5335.
3. Brooks JD, Bova GS and Isaacs WB. (1995). Prostate, 26, 35-39.
4. Chakravarti A, Heydon K, Wu CL, Hammond E, Pollack A, Roach M, Wolkov H, Okunieff P, Cox J, Fontanesi J, Abrams R, Pilepich M and Shipley W. (2003). J. Clin. Oncol., 21, 3328-3334.
5. Clark J, Lu YJ, Sidhar SK, Parker C, Gill S, Smedley D, Hamoudi R, Linehan WM, Shipley J and Cooper CS. (1997). Oncogene, 15, 2233-2239.
6. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF and Levine AJ. (1994). Cancer Res., 54, 794-799.
7. Cornford P, Evans J, Dodson A, Parsons K, Woolfenden A, Neoptolemos J and Foster CS. (1999). Am. J. Pathol., 154, 137-144.
8. Cox D and Oakes D. (1984). Analysis of Survival Data. Chapman-Hall: New York.
9. Feber A, Clark J, Goodwin G, Dodson AR, Smith PH, Fletcher A, Edwards S, Flohr P, Falconer A, Roe T, Kovacs G, Dennis N, Fisher C, Wooster R, Huddart R, Foster CS and Cooper CS. (2004). Oncogene, 23, 1627-1630.
10. Foster CS. (2000). Prostate Suppl., 9, 4-14.
11. Foster CS, Bostwick DG, Bonkhoff H, Damber JE, van der KT, Montironi R and Sakr WA. (2000). Scand. J. Urol. Nephrol. Suppl., 19-43.
12. Foster CS and Sakr WA. (2001). Curr. Diagn. Pathol., 7, 4-14.
13. Gao X, Chen YQ, Wu N, Grignon DJ, Sakr W, Porter AT and Honn KV. (1995). Oncogene, 11, 1395-1398.
14. Giangrande PH, Hallstrom TC, Tunyaplin C, Calame K and Nevins JR. (2003). Mol. Cell. Biol., 23, 3707-3720.
15. Greene FL, Balch CM, Fleming ID, Fritz A, Haller DG, Morrow M and Page DL. (2002). AJCC Cancer Staging Handbook 6th ed. Springer: New York.
16. Heidenberg HB, Sesterhenn IA, Gaddipati JP, Weghorst CM, Buzard GS, Moul JW and Srivastava S. (1995). J. Urol., 154, 414-421.
17. Huang E, Ishida S, Pittman J, Dressman H, Bild A, Kloos M, D'Amico M, Pestell RG, West M and Nevins JR. (2003). Nat. Genet., 34, 226-230.
18. Humbert PO, Verona R, Trimarchi JM, Rogers C, Dandapani S and Lees JA. (2000). Genes Dev., 14, 690-703.
19. Kaplan EL and Meier P. (1958). J. Am. Stat. Assoc., 53, 457-481.
20. Kibel AS and Isaacs WB. (2000). Urology, 55, 316-322.
21. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA and Chinnaiyan AM. (2003). Proc. Natl. Acad. Sci. USA, 100, 11606-11611.
22. Konishi N, Nakamura M, Kishi M, Nishimine M, Ishida E and Shimada K. (2002). Jpn. J. Cancer Res., 93, 767-773.
23. Lapointe J, Chunde L, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, Ekman P, DeMarzo AM, Tibshirani R, Botstein D, Brown PO, Brooks JD and Pollack JR. (2004). Proc. Natl. Acad. Sci. USA, 101, 811-816.
24. Leite KR, Franco MF, Srougi M, Nesrallah LJ, Nesrallah A, Bevilacqua RG, Darini E, Carvalho CM, Meirelles MI, Santana I and Camara-Lopes LH. (2001). Mod. Pathol., 14, 428-436.
25. Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS and Nevins JR. (1998). Genes Dev., 12, 2120-2130.
26. Martelli F, Hamilton T, Silver DP, Sharpless NE, Bardeesy N, Rokas M, DePinho RA, Livingston DM and Grossman SR. (2001). Proc. Natl. Acad Sci. USA, 98, 4455-4460.
27. Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD and Helin K. (2001). Genes Dev., 15, 267-285.
28. Osman I, Drobnjak M, Fazzari M, Ferrara J, Scher HI and Cordon-Cardo C. (1999). Clin. Cancer Res., 5, 2082-2088.
29. Shaaban AM, Sloane JP, West CR, Moore FR, Jarvis C, Williams EM and Foster CS. (2002). Am. J. Surg. Pathol., 26, 421-430.
30. Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwilliam R, Ross M, Linehan WM, Birdsall S, Shipley J and Cooper CS. (1996). Hum. Mol. Genet., 5, 1333-1338.
31. Skalsky YM, Ajuh PM, Parker C, Lamond AI, Goodwin G and Cooper CS. (2001). Oncogene, 20, 178-187.
32. Sobin LH and Wittekind C. (1997). TNM Classification of Malignant Tumours. Wiley-Liss: New York, pp 170-173.
33. Theodorescu D, Broder SR, Boyd JC, Mills SE and Frierson Jr HF. (1997). J. Urol., 158, 131-137.
34. Tomovska S, Richter J, Suess K, Wagner U, Rozenblum E, Gasser TC, Moch H, Mihatsch MJ, Sauter G and Schraml P. (2001). Int. J. Oncol., 18, 1239-1244.
35. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA and Chinnaiyan AM. (2002). Nature, 419, 624-629.
36. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML and Leone G. (2001). Nature, 414, 457-462.